Objetivo - Em 1985, a proporcao de portadores de SIDU era de vinte e quatro homens para uma mulher. Atualmente, o numero de mulheres infectadas e de 50 por cento e a maioria encontra-se em idade reprodutiva.
Mathias, Cícero Venneri [UNIFESP]
core
Management of CMV encephalitis with persistent CSF CMV DNA in a patient with HIV: a case report of successful treatment with ganciclovir-foscarnet combination therapy. [PDF]
Tanyel E +4 more
europepmc +1 more source
Diabetes Mellitus is a Risk Factor for Developing CMV Retinitis in Solid Organ Transplant Recipients: A Case-control Study. [PDF]
Bharaj DK +11 more
europepmc +1 more source
Clinical and genotypic characteristics of antiviral-resistant herpes simplex virus 1 and 2 infections: a case series. [PDF]
Ibrahim R +9 more
europepmc +1 more source
Greater Efficacy of Cidofovir Than of Foscarnet for the Treatment of Acyclovir-Resistant Herpes Simplex Virus Infection After Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]
Kong J +6 more
europepmc +1 more source
Refractory CMV Enteritis in Small Bowel Transplantation: A Case Highlighting the Challenges of Balancing Immunosuppression and Novel Antiviral Therapies. [PDF]
Al-Saud AA +6 more
europepmc +1 more source
Acquired immunodeficiency syndrome-associated cytomegalovirus encephalitis: clinical, imaging, and follow-up characteristics of 11 cases. [PDF]
Wu D +5 more
europepmc +1 more source
Reversion of Val(Ganciclovir)-Resistance-Associated Mutations in Two SOT Patients with Mismatched Serostatus for CMV (D+/R-). [PDF]
Seminari E +9 more
europepmc +1 more source
Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies. [PDF]
Karimzadeh I, Kane-Gill SL, Ma B.
europepmc +1 more source
Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient. [PDF]
Joshua B +5 more
europepmc +1 more source

